MitoBloCK-6 is primarily used in research settings to study mitochondrial dynamics and function. It is known for its ability to inhibit the Drp1 protein, which plays a crucial role in mitochondrial fission. By blocking Drp1, researchers can investigate the effects of impaired mitochondrial division on cellular processes, such as apoptosis, metabolism, and cell signaling. This makes it a valuable tool for understanding diseases linked to mitochondrial dysfunction, including neurodegenerative disorders, cardiovascular diseases, and cancer. Additionally, it helps in exploring potential therapeutic strategies targeting mitochondrial dynamics.